Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425, USA.
Curr Opin Infect Dis. 2012 Aug;25(4):458-63. doi: 10.1097/QCO.0b013e3283551dbd.
This review discusses the latest approaches to the diagnosis and treatment of patients with strongyloidiasis, with an emphasis on infection in the immunocompromised host and the risk for disseminated strongyloidiasis.
The differences in acute, chronic, accelerated autoinfection, and disseminated disease in Strongyloides stercoralis infection are explored with particular emphasis on early diagnosis, treatment, and prevention. The goals of treatment are investigated for the different infection states. Predisposing risks for dissemination are delineated, and the roles played for newer diagnostics in the identification of at-risk individuals are detailed.
The use of newer diagnostic tests and broader screening of immunocompromised patients from Strongyloides-endemic areas is of paramount importance, particularly if prevention of life-threatening dissemination is the goal.
本文讨论了当前针对粪类圆线虫病患者的诊断和治疗方法,重点关注免疫功能低下宿主的感染和播散性粪类圆线虫病的风险。
本文探讨了粪类圆线虫感染中急性、慢性、加速性自身感染和播散性疾病的差异,特别强调了早期诊断、治疗和预防。研究了不同感染状态的治疗目标。阐述了播散的诱发风险,并详细介绍了新诊断方法在识别高危人群中的作用。
对来自粪类圆线虫流行地区的免疫功能低下患者进行新的诊断检测和更广泛的筛查至关重要,特别是如果目标是预防危及生命的播散。